Menlo Therapeutics Revenue and Competitors

Claim your profile

Location

$159.8M

Total Funding

Industry

Estimated Revenue & Valuation

  • Menlo Therapeutics's estimated annual revenue is currently $10.6M per year.(i)
  • Menlo Therapeutics's estimated revenue per employee is $3,546,667
  • Menlo Therapeutics's total funding is $159.8M.

Employee Data

  • Menlo Therapeutics has 3 Employees.(i)
  • 0

keywords:N/A

$159.8M

Total Funding

3

Number of Employees

$10.6M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Menlo Therapeutics News

2022-04-13 - VYNE Therapeutics (NASDAQ:VYNE) Upgraded by Zacks ...

The company's product pipeline consist FMX103 and FCD105 which are in clinical stage. VYNE Therapeutics Inc., formerly known as Menlo...

2022-04-06 - Corcept Therapeutics Announces Appointment of Three Senior Leaders

MENLO PARK, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged...

2022-03-22 - Bay Area's first stock debut in nearly 2 months, by AN2 ...

The Menlo Park biotech raised $69 million in an offering that priced in the middle of its target range but sold 900,000 more shares than...

2019-09-12 - Janus Henderson Group PLC Lowers Holdings in Menlo Therapeutics Inc (NASDAQ:MNLO)

Janus Henderson Group PLC lowered its position in Menlo Therapeutics Inc (NASDAQ:MNLO) by 0.5% during the 2nd quarter, according to ...

2019-09-12 - JPMorgan Chase & Co. Lowers Stock Holdings in Menlo Therapeutics Inc (NASDAQ:MNLO)

JPMorgan Chase & Co. reduced its position in shares of Menlo Therapeutics Inc (NASDAQ:MNLO) by 4.1% in the 2nd quarter, according to the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0M3-25%$26M
#2
$0.2M3N/AN/A
#3
$0.2M3N/AN/A
#4
$0.2M3N/AN/A
#5
$0.2M3N/AN/A